Stericycle Inc. (NASDAQ:SRCL) – Research analysts at Northcoast Research lowered their Q1 2017 EPS estimates for shares of Stericycle in a report released on Tuesday. Northcoast Research analyst E. Snyder now expects that the brokerage will post earnings per share of $1.12 for the quarter, down from their prior forecast of $1.19. Northcoast Research currently has a “Neutral” rating on the stock. Northcoast Research also issued estimates for Stericycle’s Q2 2017 earnings at $1.21 EPS, Q3 2017 earnings at $1.23 EPS, Q4 2017 earnings at $1.31 EPS and FY2017 earnings at $4.86 EPS.

SRCL has been the subject of a number of other reports. Macquarie assumed coverage on Stericycle in a research report on Thursday, August 25th. They set a “neutral” rating and a $96.00 target price for the company. Jefferies Group reaffirmed a “buy” rating and issued a $112.50 target price (down previously from $125.00) on shares of Stericycle in a report on Wednesday, September 7th. Zacks Investment Research raised Stericycle from a “sell” rating to a “hold” rating in a report on Monday, July 4th. Imperial Capital cut Stericycle from an “in-line” rating to an “underperform” rating and lowered their target price for the stock from $100.00 to $93.50 in a report on Friday, July 29th. Finally, Wellington Shields cut Stericycle from an “accumulate” rating to a “hold” rating in a report on Friday, July 29th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $110.32.

Stericycle (NASDAQ:SRCL) traded up 0.64% during trading on Wednesday, reaching $77.50. The company had a trading volume of 649,333 shares. The firm has a market capitalization of $6.59 billion, a PE ratio of 27.28 and a beta of 0.27. The firm’s 50 day moving average price is $84.76 and its 200 day moving average price is $102.60. Stericycle has a 12-month low of $76.76 and a 12-month high of $151.57.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/stericycle-inc-srcl-forecasted-to-post-q1-2017-earnings-of-1-12-per-share.html

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.18. The business had revenue of $891.60 million for the quarter, compared to analysts’ expectations of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The firm’s quarterly revenue was up 24.6% compared to the same quarter last year. During the same quarter last year, the business earned $1.14 earnings per share.

In related news, Director Mark C. Miller sold 34,835 shares of the company’s stock in a transaction dated Friday, July 8th. The stock was sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the sale, the director now owns 244,284 shares in the company, valued at approximately $25,532,563.68. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Mark C. Miller sold 24,665 shares of the company’s stock in a transaction dated Friday, July 1st. The shares were sold at an average price of $104.55, for a total value of $2,578,725.75. Following the sale, the director now owns 229,449 shares in the company, valued at approximately $23,988,892.95. The disclosure for this sale can be found here. Corporate insiders own 3.30% of the company’s stock.

Large investors have recently made changes to their positions in the stock. Balentine LLC raised its stake in shares of Stericycle by 34.9% in the first quarter. Balentine LLC now owns 1,064 shares of the company’s stock valued at $134,000 after buying an additional 275 shares during the last quarter. Pinkerton Retirement Specialists LLC acquired a new stake in shares of Stericycle during the second quarter valued at approximately $131,000. Canada Pension Plan Investment Board raised its stake in shares of Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock valued at $179,000 after buying an additional 497 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock valued at $149,000 after buying an additional 41 shares during the last quarter. Finally, Meeder Asset Management Inc. acquired a new stake in shares of Stericycle during the second quarter valued at approximately $155,000. Institutional investors own 92.80% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.